How does Wegovy work for weight loss?
How does Wegovy work? It mimics GLP-1 to reduce appetite and slow stomach emptying. Effects build over weeks as the dose is increased.
Key facts
- Semaglutide + B12 is $157/month (billed $157 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.
Wegovy (semaglutide) is a once-weekly injection used with diet and physical activity for chronic weight management. It works mainly by lowering appetite and increasing feelings of fullness, so you tend to eat fewer calories. This page explains how Wegovy works in your body, what you might notice early on, and why timelines differ person to person. If you are considering a compounded option, Vitals Vault offers compounded semaglutide, which is not the same as brand Wegovy.
- Wegovy works by acting like GLP-1 to reduce appetite and slow stomach emptying.
- It also affects brain pathways involved in hunger and fullness, helping you eat less.
- Benefits tend to build over time because the dose is increased gradually to improve tolerability.
- Results vary based on dose, side effects, adherence, diet, activity, and other health conditions.
Answer: how does Wegovy work?
- Drug class
- GLP-1 receptor agonist (semaglutide)
- How it is taken
- Injection under the skin once weekly, with gradual dose escalation
- What it is approved for
- Chronic weight management in adults with obesity or overweight with at least one weight-related condition; also approved for certain adolescents
What Wegovy changes in your body
It reduces appetite signals
Semaglutide activates GLP-1 receptors in the brain areas that regulate hunger and satiety (fullness). For many people, that means less food noise, smaller portions feeling satisfying, and fewer urges to snack. This is one reason weight change can occur even without feeling like you are constantly dieting.
It slows stomach emptying
Wegovy can slow how quickly food leaves your stomach, especially early in treatment. Slower emptying can increase fullness after meals and may contribute to nausea or reflux in some people. Over time, the stomach-emptying effect tends to lessen compared with early treatment.
It supports healthier glucose patterns
GLP-1 medicines can improve blood sugar regulation, including increasing insulin release when glucose is high and reducing glucagon. Even if you do not have diabetes, steadier glucose swings can make appetite easier to manage for some people. If you use insulin or a sulfonylurea, low blood sugar risk is higher and needs clinician oversight.
Why the dose is increased gradually
Wegovy is started at a low dose and increased in steps to improve tolerability, mainly gastrointestinal side effects. Because of that schedule, the full appetite effect often builds over weeks to months rather than happening all at once. Your clinician may pause or adjust escalation if side effects are limiting.
Why results vary
Response depends on reaching and tolerating an effective dose, taking it consistently, and maintaining nutrition and activity changes. Side effects can limit dose escalation for some people, while others may not respond strongly even at higher doses. Other factors include sleep, stress, other medications, and medical conditions that affect weight.
| What you notice | Possible explanation | What to discuss with a clinician |
|---|---|---|
| Less hunger, earlier fullness | Expected GLP-1 effects on appetite and stomach emptying | Whether nutrition targets and protein intake support satiety |
| Nausea or heartburn | GI side effects are common, especially during dose increases | Ways to reduce symptoms and whether escalation should slow |
| No change in appetite yet | Dose may still be low early in titration, or individual response differs | Whether the dosing schedule is on track and realistic expectations |
| Weight plateaus | Energy intake may match energy needs again as your body adapts | Nutrition, activity, sleep, and whether another strategy is needed |
When to talk to a clinician
Severe stomach pain or vomiting
Persistent or severe abdominal pain, especially if it radiates to your back or comes with vomiting, can be a warning sign of pancreatitis or gallbladder disease. These are uncommon but serious risks listed for semaglutide. Seek urgent evaluation rather than trying to push through symptoms.
Symptoms of dehydration or kidney problems
Ongoing vomiting or diarrhea can lead to dehydration, which can worsen kidney function. Contact a clinician promptly if you cannot keep fluids down, feel faint, or notice reduced urination. Monitoring is especially important if you already have kidney disease.
A neck lump or hoarseness
Semaglutide carries a boxed warning about thyroid C-cell tumors seen in rodents, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Report a neck mass, trouble swallowing, or persistent hoarseness to a clinician.
Low blood sugar risk with certain meds
Wegovy alone is not expected to cause low blood sugar, but risk increases if you also use insulin or a sulfonylurea. If you have shakiness, sweating, confusion, or fainting, get help right away. Ask your prescriber how to monitor safely if you take diabetes medicines.
If you are not tolerating dose increases
If nausea, constipation, diarrhea, or reflux is interfering with eating and hydration, tell your clinician. They may recommend symptom strategies, slower escalation, or a different plan. Do not change how you take the medication without medical guidance.
Pro tips for setting expectations
Expect a gradual build
Because Wegovy is titrated, appetite effects often strengthen as the dose increases.
Track more than weight
Hunger, portions, cravings, and side effects help your clinician fine-tune the plan.
Side effects can be a signal
New or worsening GI symptoms during escalation are common, but severe pain is not.
Ask about interactions
Slower stomach emptying can affect how some oral medicines are absorbed.
Know what product you are using
Compounded semaglutide is not brand Wegovy and is not FDA-approved.
Frequently Asked Questions
Does Wegovy work?
In clinical trials, Wegovy (semaglutide) used with diet and physical activity led to clinically meaningful weight reduction for many participants. Individual response varies, and some people stop early due to side effects or limited benefit. Your clinician can help set expectations and monitor safety.
How fast does Wegovy work?
Many people notice appetite changes early, but weight change typically builds over time because the dose is increased gradually. The exact timeline varies based on tolerability, dose progression, and lifestyle factors. If you are unsure it is working, discuss your dosing schedule and goals with your clinician.
How quickly does Wegovy work?
Wegovy can start affecting hunger and fullness soon after starting, but the full effect often takes longer as you reach higher doses. Side effects can also influence how quickly you can increase the dose. A clinician can help interpret what is normal early on.
How long for Wegovy to work?
Wegovy is designed for long-term weight management, and benefits are expected to build across the titration period and beyond. If you are not seeing changes after you have had time to reach a tolerated dose, your clinician may reassess the plan. Do not adjust dosing on your own.
How does Wegovy work compared with compounded semaglutide?
Brand Wegovy contains semaglutide and is FDA-approved, while compounded semaglutide is prepared by a pharmacy for an individual prescription and is not FDA-approved. The intended mechanism is similar because the active ingredient is semaglutide, but quality and dosing can differ by compounder. If you use a compounded product, ask your prescriber what to monitor.